Exploring New Strategies for Optimizing Solubility & Bioavailability of Current and Future Drug Products
Featuring Representation From:
- Novartis
- Aptuit
- Merck
- Quotient Clinical
- GlaxoSmithKline
- Sirius Analytical
- Roche
- Celgene
- Capsugel
- Patheon
- Agios
- Takeda
- Pion
- Cubist
- H. Lundbeck
- Agere
- Center for Pharmaceutical Physics
Join industry innovators and key decision-makers to explore the latest research into solubility and bioavailability. Featured case studies include:
- Optimizing Formulation and Product Development in Early Clinical Research
-Presentation by Jason Vaughn, Patheon - Nanosuspension Formulation and Process Optimization for Improved Bioavailability of Poorly Soluble Drug Compounds
-Presented by Indrajit Ghosh, Celgene - Successful Formulation Strategies for Amorphous Solid Dispersions
-Presented by Duk Soon Choi, Roche - Role of Small Molecule Colloid Formation on Oral Absorption
-Presented by Liping Zhou, Novartis - Effects of Manufacturing Process on Solid Dispersion Stability and Bio-Performance
-Presented by Michael Lowinger, Merck - Adapting QbD Principles to Solubilization Formulation Development
-Presented by Marshall Crew, Agere Pharmaceuticals - Amorphous Spray-Dried Dispersions in Early Phase Development
-Presented by Pratik Saha, GlaxoSmithKline
And many more! Including special coverage on:
- Intellectual Property Considerations for Solid Form Drug Compounds
- Supersaturation & Precipitation Behavior of Poorly Soluble Drugs
- Rational Formulation Design for Poorly Soluble Drugs
- Co-Crystallization Techniques to Optimize Solubility
- Innovations in Discovery Pharmaceutics for Poorly Soluble Compounds
- Recent Developments in Lipid-Based Drug Delivery
- Considerations for Toxicology Formulations of Poorly Soluble Compounds
Reviews
There are no reviews yet.